
Investments
93Portfolio Exits
42Funds
9About Cross Creek
Cross Creek is a venture capital firm founded in 2006 inside of Wasatch Advisors. Through its direct investment strategy and fund investment strategy the firm seeks to invest in what we believe are high quality late stage companies and top-tier venture capital funds. The strategies are mutually beneficial in their goal to strengthen ties between private and public investors and to achieve above market returns for limited partners.

Want to inform investors similar to Cross Creek about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Cross Creek News
Jun 13, 2023
Carrum Health recently announced an oversubscribed $45 million Series B financing led by OMERS Growth Equity. And Revelation Partners joined the round along with return investors Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. Carrum Health plans to use the funding to expand its growing oncology benefit offerings and scale its surgical care service lines to give employees access to the top 10% of doctors and providers across the country while helping employers control healthcare spending. Carrum Health’s unique value-based program addresses acute care scenarios like orthopedic surgery and cancer treatment, which accounts for nearly half of total employer spend. And Carrum Health’s COE solution not only reduces unnecessary procedures by as much as 30% – leading to better patient outcomes – it can result in savings of up to 45% per care episode, according to a published study by the RAND Corporation. The company has seen momentum with its pioneering oncology COE offering and currently partners with top cancer care providers across the country, including AccessHope LLC, City of Hope, GRAIL LLC, Memorial Sloan Kettering Cancer Center and University of Chicago Medicine. In 2022 alone, the company added six new partners, including CVS, Included Health, Accolade, Rightway, SWORD Health and Virgin Pulse. KEY QUOTES: “We are very excited to partner with Carrum Health, a pioneering and differentiated player in the healthcare space, that offers an innovative, scalable approach in the shift to value-based care. With its Centers of Excellence (COE) network, digital platform and data-driven surgical episode bundling capabilities, Carrum Health has created a solution that allows for real-time and measurable value to employers, as well as a superior patient and clinician experience. The company is well-positioned to transform how healthcare is delivered and paid for, and we look forward to supporting the management team in realizing that vision.” — Teresa Lee, managing director of OMERS Growth Equity – who will join Carrum Health’s board of directors “Every business in America is looking to manage costs, but they can’t afford to sacrifice the benefits they offer employees. Carrum Health firmly believes that the path to reducing healthcare costs starts with delivering higher quality care. Our COE solution is proven to deliver significant savings on healthcare spend and generate measurable cost savings within the first year of deployment. In a time when employers are looking to consolidate benefits, we’ve seen 100% year-over-year growth in new customers and zero churn of existing customers.” — Carrum Health CEO Sach Jain
Cross Creek Investments
93 Investments
Cross Creek has made 93 investments. Their latest investment was in Carrum Health as part of their Series B on May 5, 2023.

Cross Creek Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/30/2023 | Series B | Carrum Health | $45M | No | 11 | |
5/3/2023 | Series C | Novidea | $50M | Yes | 6 | |
5/5/2022 | Series E | Fictiv | $100M | Yes | 2 | |
8/10/2021 | Series E | |||||
4/14/2021 | Series D |
Date | 5/30/2023 | 5/3/2023 | 5/5/2022 | 8/10/2021 | 4/14/2021 |
---|---|---|---|---|---|
Round | Series B | Series C | Series E | Series E | Series D |
Company | Carrum Health | Novidea | Fictiv | ||
Amount | $45M | $50M | $100M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 11 | 6 | 2 |
Cross Creek Portfolio Exits
42 Portfolio Exits
Cross Creek has 42 portfolio exits. Their latest portfolio exit was Scopely on April 05, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
4/5/2023 | Acquired | 23 | |||
11/17/2021 | IPO | Public | 14 | ||
7/28/2021 | Reverse Merger | 6 | |||
Date | 4/5/2023 | 11/17/2021 | 7/28/2021 | ||
---|---|---|---|---|---|
Exit | Acquired | IPO | Reverse Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 23 | 14 | 6 |
Cross Creek Fund History
9 Fund Histories
Cross Creek has 9 funds, including Cross Creek Capital Partners IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
12/31/2016 | Cross Creek Capital Partners IV | Fund Of Funds | Closed | 1 | |
8/3/2011 | Cross Creek Capital Partners II LP | ||||
3/10/2008 | Cross Creek Capital Partners LLC | ||||
9/19/2006 | Cross Creek Capital | ||||
9/1/2006 | Cross Creek Capital Employees' Fund |
Closing Date | 12/31/2016 | 8/3/2011 | 3/10/2008 | 9/19/2006 | 9/1/2006 |
---|---|---|---|---|---|
Fund | Cross Creek Capital Partners IV | Cross Creek Capital Partners II LP | Cross Creek Capital Partners LLC | Cross Creek Capital | Cross Creek Capital Employees' Fund |
Fund Type | Fund Of Funds | ||||
Status | Closed | ||||
Amount | |||||
Sources | 1 |
Cross Creek Team
8 Team Members
Cross Creek has 8 team members, including current President, Chief Investment Officer, John Zimmerman.
Name | Work History | Title | Status |
---|---|---|---|
John Zimmerman | President, Chief Investment Officer | Current | |
Name | John Zimmerman | ||||
---|---|---|---|---|---|
Work History | |||||
Title | President, Chief Investment Officer | ||||
Status | Current |